Xanthohumol targets the ERK1/2‑Fra1 signaling axis to reduce cyclin D1 expression and inhibit non‑small cell lung cancer

Feng Gao(Northeast Normal University), Wei Li(Guangzhou University of Chinese Medicine)
Oncology Reports
July 20, 2020
Cited by 21


Related Papers